Histone H3 lysine-trimethylation markers are decreased by recombinant methioninase and increased by methotrexate at concentrations which inhibit methionine-addicted osteosarcoma cell proliferation-Reference-Cited by-同舟云学术

Histone H3 lysine-trimethylation markers are decreased by recombinant methioninase and increased by methotrexate at concentrations which inhibit methionine-addicted osteosarcoma cell proliferation

Published:2021-12 Issue: Volume:28 Page:101177
ISSN:2405-5808
Container-title:Biochemistry and Biophysics Reports
language:en
Short-container-title:Biochemistry and Biophysics Reports

Author:

Aoki Yusuke^ORCID,Tome Yasunori^ORCID,Han Qinghong,Yamamoto Jun^ORCID,Hamada Kazuyuki,Masaki Noriyuki^ORCID,Bouvet Michael^ORCID,Nishida Kotaro,Hoffman Robert M.

Publisher

Elsevier BV

Subject

Biochemistry,Biophysics

Reference40 articles.

1. High in vivo rates of methionine biosynthesis in transformed human and malignant rat cells auxotrophic for methionine;Hoffman;Proc. Natl. Acad. Sci. U. S. A.,1976

2. Elevated overall rates of transmethylation in cell lines from diverse human tumors;Stern,1984

3. Histone methylation status of H3K4me3 and H3K9me3 under methionine restriction is unstable in methionine-addicted cancer cells, but stable in normal cells;Yamamoto;Biochem. Biophys. Res. Commun.,2020

4. Overexpression and large-scale production of recombinant L-methionine-alpha-deamino-gamma-mercaptomethane-lyase for novel anticancer therapy;Tan;Protein Expr. Purif.,1997

5. Much more than you expected: the non-DHFR-mediated effects of methotrexate;Sramek;Biochim. Biophys. Acta Gen. Subj.,2017

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA-Binding Agent Trabectedin Combined With Recombinant Methioninase Is Synergistic to Decrease Fibrosarcoma Cell Viability and Induce Nuclear Fragmentation But Not Synergistic on Normal Fibroblasts;Anticancer Research;2024-05-31

2. Reduction of Tumor Biomarkers from very High to Normal and Extensive Metastatic Lesions to Undetectability in a Patient With Stage IV HER2-positive Breast Cancer Treated With Low-dose Trastuzumab Deruxtecan in Combination With Oral Recombinant Methioninase and a Low-methionine Diet;Anticancer Research;2024-03-27

3. Extensive Synergy Between Recombinant Methioninase and Eribulin Against Fibrosarcoma Cells But Not Normal Fibroblasts;Anticancer Research;2024-02-29

4. Extensive Shrinkage and Long-term Stable Disease in a Teenage Female Patient With High-grade Glioma Treated With Temozolomide and Radiation in Combination With Oral Recombinant Methioninase and a Low-methionine Diet;In Vivo;2024

5. Targeting Methionine Addiction Combined With Low-dose Irinotecan Arrested Colon Cancer in Contrast to High-dose Irinotecan Alone, Which Was Ineffective, in a Nude-mouse Model;In Vivo;2024